These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11361629)

  • 1. Viramune Expanded Access Program begins.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361629
    [No Abstract]   [Full Text] [Related]  

  • 2. Nevirapine expanded access.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine expanded access program begins.
    AIDS Patient Care STDS; 1996 Apr; 10(2):131. PubMed ID: 11361694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nevirapine--the first non-nucleoside inhibitor of reverse transcriptase in the battle against AIDS].
    Wiese E
    Pharm Unserer Zeit; 1997 Mar; 26(2):99-100. PubMed ID: 9289739
    [No Abstract]   [Full Text] [Related]  

  • 5. [New combination medications].
    Agosto M
    Sidahora; 1997; ():43-6. PubMed ID: 11364501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine approval expands combo possibilities--and HIV suppression.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two studies suggest nevirapine benefit for children.
    AIDS Patient Care STDS; 1997 Jun; 11(3):195. PubMed ID: 11361798
    [No Abstract]   [Full Text] [Related]  

  • 8. Nevirapine--first of a new class of drugs.
    PI Perspect; 1996 Sep; (No 19):9-10. PubMed ID: 11363907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination trial with nevirapine underway.
    AIDS Patient Care STDS; 1996 Apr; 10(2):130-1. PubMed ID: 11361693
    [No Abstract]   [Full Text] [Related]  

  • 10. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
    Fleck F
    Bull World Health Organ; 2004 Jan; 82(1):77-8. PubMed ID: 15106303
    [No Abstract]   [Full Text] [Related]  

  • 14. Current clinical treatments of AIDS.
    Murphy EM; Jimenez HR; Smith SM
    Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
    [No Abstract]   [Full Text] [Related]  

  • 15. [AIDS: the myth of Sisyphus].
    Jaubert D
    Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577
    [No Abstract]   [Full Text] [Related]  

  • 16. Nevirapine-plus-protease studies under way.
    AIDS Alert; 1996 Oct; 11(10):119. PubMed ID: 11363856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 18. Expanded access programs expanding.
    Proj Inf Perspect; 1997 Nov; (23):20-1. PubMed ID: 11365376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification.
    Martínez E; Gatell JM
    AIDS; 2007 Aug; 21(13):1829-30. PubMed ID: 17690588
    [No Abstract]   [Full Text] [Related]  

  • 20. UCLA researcher demonstrates new ways to assess drug treatment in HIV-infected patients.
    AIDS Patient Care STDS; 1996 Jun; 10(3):189-90. PubMed ID: 11361638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.